Friday, 18 September 2026 PDT | 07:18 AM
The 1 News Alt Logo Text Smart News for Global Indians

Artificial intelligence reads biopsies in Lleida to decipher why uniform gastric cancer treatments fail

AI News September 18, 2026 06:30 PM
AI News

Artificial intelligence reads biopsies in Lleida to decipher why uniform gastric cancer treatments fail

Google News - AI

Artificial intelligence reads biopsies in Lleida to decipher why uniform gastric cancer treatments fail

AI will read biopsies in Lleida to personalize therapies against gastric cancer. The IRBLleida project receives 240,000 euros to identify immunological subtypes and adapt treatment to each patient.

Add APD as a preferred Google source for free.

Stay informed with the latest current news.

The Association Against Cancer in Lleida has celebrated the conference "Research Projects that Drive Life Projects" with a proposal focused on applying artificial intelligence to the analysis of tumor biopsies.

The core of the project stems from a specific clinical difficulty. The same treatment does not yield the same response in all gastric cancer patients, and the work presented by Dr. Robert Montal seeks to distinguish immunological subtypes to better adjust therapy in each case.

Robert Montal presented a project with AI to analyze tumor biopsies in Lleida

During the conference organized on the occasion of World Cancer Research Day, Montal presented a line of work aimed at reading images of tumor biopsies with artificial intelligence tools.

The objective is to identify different immunological subtypes of gastric cancer.

With this classification, the project aims to promote specialized treatments for each patient. The approach is based on the premise that the response to therapies is not uniform and that this difference requires a more refined clinical selection.

Aid of 240,000 euros will finance three years of research at IRBLleida

Montal is developing this work as a medical oncologist and researcher at IRBLleida, a connection that places the initiative in the care setting and also in the biomedical research field of Lleida.

In the same environment, funding for oncological research has had other recent expressions, such as donations for oncological research promoted in the city and other scientific dissemination activities linked to IRBLleida and the University of Lleida.

The initiative has received Senior Clinical Researcher AECC 2026 Aid. The grant provides 240,000 euros spread over three years to support the project's development.

The conference was titled "Research Projects that Drive Life Projects".